Clinical Trial Update: A Study to Evaluate YH003 in Combination With Toripalimab (Anti-PD-1 mAb) in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating YH003 in combination with toripalimab in advanced solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Toripalimab (Toripalimab)
• YH003 (YH003)

Snippet

Sponsor: Eucure (Beijing) Biopharma Co., Ltd | Conditions: Advanced Solid Tumors | Phase 1, Phase 2 | Status: COMPLETED